drugset / Trial / NCT00866645
A Study To Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of Schizophrenia
Phase 2/3
Completed
240 enrolled
Shanghai Mental Health Center
Shanghai Hotmed Sciences Co.,LTD · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The primary objective of this study is to evaluate the efficacy and safety of Intramuscular Levosulpiride in the treatment of Chinese patients with Agitation Of Schizophrenia compared with Intramuscular Haloperidol by evaluating the change of PANSS-EC total scores at end of study (72 hours after first dosing) from baseline.
Timeline
- Start
- 2009-02
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Haloperidol | Other / unclassified | 5 mg | Intramuscular |
| Subject | Levosulpiride | Small molecule | 50 mg | Intramuscular |
Indications
No indication recorded.